Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

P
P. Tafti, Ahmad

University of Pittsburgh
(P 244) A DEEP FEW-SHOT META-LEARNING STRATEGY FOR AUTONOMOUS CLASSIFICATION OF BONE METASTASIS IN RADIONUCLIDE BONE SCANS
Ahmad P. Tafti
Favorite
Płachta, Iga

Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
(P 162) LONG TERM SAFETY AND EFFICACY OF COMBINED DOXORUBICIN-IFOSFAMIDE CHEMOTHERAPY WITH PREOPERATIVE HYPOFRACTIONATED RADIOTHERAPY IN MARGINALLY RESECTABLE SOFT TISSUE SARCOMAS
Iga Płachta
Favorite
Pabst, Kim

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen
(P 220) [68GA]GA-FAPI PET/CT AS NOVEL DIAGNOSTIC TOOL IN SARCOMA
Kim Pabst
Favorite
(P 248) FIBROBLAST ACTIVATION PROTEIN ALPHA -DIRECTED IMAGING AND THERAPY OF SOLITARY FIBROUS TUMOR
Kim Pabst
Favorite
Pacilio, Carlo Alberto

General and Oncologic Surgery, "Morgagni-Pierantoni" Hospital
(P 37) DISSECTING THE ROLE OF EXTRACELLULAR VESICLES IN THE MANAGEMENT OF GIST
Carlo Alberto Pacilio
Favorite
(P 364) EVALUATION OF THE PREDICTIVE ROLE OF SYSTEMIC AND INTRATUMORAL IMMUNITY IN PATIENTS WITH LOCALIZED LIPOSARCOMAS, MYXOFIBROSARCOMAS AND UNDIFFERENTIATED PLEOMORPHIS SARCOMAS
Carlo Alberto Pacilio
Favorite
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
Carlo Alberto Pacilio
Favorite
Paglia, Simona

Istituto Ortopedico Rizzoli IRCCS, Osteoncology- Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, Bologna, Italy
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
Simona Paglia
Favorite
Paindavoine, Sandrine

Centre Léon Bérard
(P 382) NTRK1/2/3 FUSIONS DETECTION USING RNA-SEQ IN MESENCHYMAL TUMORS REVEALS ULTRA-RARE AND HISTO-SPECIFIC TARGETABLE ALTERATIONS: EXPERIENCE OF AN EXTENSIVE ROUTINE RESEARCH PROGRAM.
Sandrine Paindavoine
Favorite
Paioli, Anna

Istituto Ortopedico Rizzoli IRCCS, Osteoncology- Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, Bologna, Italy
(P 01) EXTRASKELETAL EWING SARCOMA OF THE EXTREMITIES AND TRUNK IN < 25 YEARS OLD PATIENTS: A RETROSPECTIVE ANALYSIS OF A MONO-INSTITUTIONAL SERIES.
Anna Paioli
Favorite
Paioli, Anna

Istituto Ortopedico Rizzoli
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Anna Paioli
Favorite
Pajtler, Kristian

Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University
(P 202) INFLAMMATORY MYOFIBROBLASTIC TUMOUR WITH ROS1 GENE FUSIONS IN CHILDREN AND YOUNG ADOLESCENTS
Kristian Pajtler
Favorite
Palassini, Elena

Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
(P 14) PERCUTANEOUS CRYOABLATION OF PROGRESSING EXTRA-ABDOMINAL DESMOID TUMOURS
Elena Palassini
Favorite
(P 159) IN BETWEEN OF LYMPHOMAS AND SARCOMAS: WHERE DO HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN) STAND? A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG)
Elena Palassini
Favorite
(P 333) SYSTEMIC TREATMENT IN INTRA-ABDOMINAL DESMOID-TYPE FIBROMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE CASE SERIES ANALYSIS
Elena Palassini
Favorite
(P 342) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
Elena Palassini
Favorite
Palmerini, Emanuela

IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
(P 73) FOSTER CONSORTIUM, FIGHT OSTEOSARCOMA THROUGH EUROPEAN RESEARCH
Emanuela Palmerini
Favorite
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Emanuela Palmerini
Favorite
(P 173) SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED PRIOR ANTI–COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 UPDATE
Emanuela Palmerini
Favorite
(P 176) SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED NO PRIOR ANTI–COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 UPDATE
Emanuela Palmerini
Favorite
(P 189) INTERNATIONAL RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF ADVANCED DISEASE AND SYSTEMIC THERAPIES
Emanuela Palmerini
Favorite
(P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY
Emanuela Palmerini
Favorite
(P 437) ULTRA-RARE UNDIFFERENTIATED SMALL ROUND CELL SARCOMA: HOW SHOULD WE TREAT THEM? AN ANALYSIS FORM THE GRACEFUL PROJECT
Emanuela Palmerini
Favorite
Palomba, Annarita

Unit of Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
(P 309) CLINICAL PATHOLOGICAL CHARACTERISTICS, PATTERN OF CARE AND SURVIVAL OF NON-METASTATIC BREAST ANGIOSARCOMA
Annarita Palomba
Favorite
(P 317) PROGNOSTIC FACTORS, CLINICAL AND TOXICITY OUTCOMES FROM A LARGE COHORT OF PATIENTS WITH SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE RADIATION THERAPY
Annarita Palomba
Favorite
(P 546) PRELIMINARY CLINICAL RESULTS OF AN ONGOING PHASE II TRIAL: SPRINT (SARCOMA PREOPERATIVE RADIATION WITH SIMULTANEOUS INTEGRATED BOOST)
Annarita Palomba
Favorite
Pal, Rajesh

Precision Sarcoma Research Group, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg
(P 124) UNLOCKING THE POTENTIAL OF MEASLES VIRUS ONCOLYTIC IMMUNOTHERAPY FOR SARCOMA: BIOMARKER DISCOVERY AND THERAPEUTIC VACCINE DEVELOPMENT
Rajesh Pal
Favorite
Pal, Tuya

Vanderbilt University Medical Center
(P 160) A PROSPECTIVE STUDY EVALUATING THE ASSOCIATION OF PATIENT-REPORTED OUTCOMES WITH ACTIVITY LEVEL AND SLEEP PATTERNS IN SARCOMA SURVIVORS
Tuya Pal
Favorite
(P 210) FINANCIAL TOXICITY ASSOCIATED WITH THE TREATMENT OF SARCOMAS: A SINGLE INSTITUTION RETROSPECTIVE-PROSPECTIVE STUDY
Tuya Pal
Favorite
(P 211) AN ANALYSIS OF SELF-REPORTED DEPRESSION IN SARCOMA PATIENTS
Tuya Pal
Favorite
(P 380) NEXT GENERATION SEQUEINCING REVEALS TARGETABLE MUTATIONS IN MULTIPLE SARCOMA HISTOLOGIES
Tuya Pal
Favorite
Panahi, Babak

Department of Diagnostic and Interventional Radiology, University Medical Center Goettingen, 37075 Goettingen, Germany
(P 235) FUSION OF PREOPERATIVE IN SITU MAGNETIC RESONANCE IMAGING AND POSTOPERATIVE COMPUTED TOMOGRAPHY TO CORRELATE FUNCTIONAL IMAGING FEATURES AND PATHOLOGICAL CHARACTERISTICS OF SOFT TISSUE SARCOMA
Babak Panahi
Favorite
Pancisi, elena

Irst
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
elena Pancisi
Favorite
Panda, Goutam

Tata Memorial Hospital Mumbai
(P 436) OUTCOME PROGNOSTICATORS IN ADOLESCENTS AND ADULTS WITH BONE SARCOMAS IN LOW-MIDDLE-INCOME COUNTRIES
Goutam Panda
Favorite
Pandey, Rambha

AIIMS
(P 562) A PHASE 2, SINGLE ARM STUDY OF REGORAFENIB IN METASTATIC/UNRESECTABLE REFRACTORY SYNOVIAL SARCOMAS
Rambha Pandey
Favorite
Pandya, Susan

Servier Pharmaceuticals
(P 66) PHASE I STUDY OF THE MUTANT IDH1 INHIBITOR IVOSIDENIB: LONG-TERM SAFETY AND CLINICAL ACTIVITY IN PATIENTS WITH CONVENTIONAL CHONDROSARCOMA
Susan Pandya
Favorite
Pan, Irene

United BioSource LLC
(P 131) PATIENT-REPORTED CONTINUED BENEFITS IN PATIENTS TREATED WITH PEXIDARTINIB FOR TENOSYNOVIAL GIANT CELL TUMOR BASED ON A REAL-WORLD STUDY IN THE UNITED STATES
Irene Pan
Favorite
Pankova, Valeriya

The Institute of Cancer Research
(P 404) PROTEOMIC PROFILING OF THE SOFT TISSUE SARCOMA MICROENVIRONMENT IDENTIFIES A PROGNOSTIC SIGNATURE BASED ON PROTEOGLYCAN EXPRESSION AND CD8+ TUMOUR INFILTRATING LYMPHOCYTES
Valeriya Pankova
Favorite
Pan, Minggui

Stanford University
(P 224) CO-MUTATION-DEPENDENT PROGNOSIS IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA
Minggui Pan
Favorite
Pannella, Micaela

Istituto Ortopedico Rizzoli IRCCS, Osteoncology- Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, Bologna, Italy
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
Micaela Pannella
Favorite
(P 283) A TRIDIMENSIONAL PRECLINICAL MODEL TO STUDY HUMAN AND CANINE OSTEOSARCOMA DEVELOPMENT AND INTERACTION WITH TUMOR MICROENVIRONMENT
Micaela Pannella
Favorite
Pantaleo, Maria

Institute of Hematology and Medical Oncology L & A Seragnoli and Interdepartmental Centre for Cancer Research G Prodi
(P 27) A MULTICENTER RETROSPECTIVE STUDY ON THE CLINICAL BEHAVIOR OF SDH-DEFICIENT GIST
Maria Pantaleo
Favorite
(P 49) EFFICACY OF RIPRETINIB IN A MULTICENTER EXPANDED ACCESS PROGRAM IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS HARBOURING NON-KIT EXON 11 MUTATIONS.
Maria Pantaleo
Favorite
Pantano, Francesco

Fondazione Policlinico Universitario Campus Bio-Medico
(P 263) HER2 AS A POTENTIAL NOVEL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMAS
Francesco Pantano
Favorite
(P 264) CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS AND TRABECTEDIN IN SOFT TISSUE SARCOMA: A NOVEL POTENTIAL SYNERGY?
Francesco Pantano
Favorite
Pantziarka, Pan

Anticancer Fund
(P 73) FOSTER CONSORTIUM, FIGHT OSTEOSARCOMA THROUGH EUROPEAN RESEARCH
Pan Pantziarka
Favorite
Pantziarka, Pan

George Pantziarka TP53 Trust/Anticancer Fund
(P 90) RESULTS FROM AN INTERNATIONAL SURVEY OF BONE SARCOMA PATIENTS
Pan Pantziarka
Favorite
Paoletti, Xavier

Institute Curie
(P 212) REPORT ON THE EWING SARCOMA PATIENTS ENROLLED IN ARM D OF THE ACSE-ESMART TRIAL: PHASE I/II STUDY OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IRINOTECAN IN CHILDREN WITH ADVANCED MALIGNANCIES
Xavier Paoletti
Favorite
Papakonstantinou, Andri

Karolinska institutet
(P 243) EVALUATION OF THE USE OF WGS IN ROUTINE DIAGNOSTICS FOR BONE AND SOFT TISSUE TUMORS
Andri Papakonstantinou
Favorite
Papakonstantinou, Andri

Karolinska University Hospital
(P 278) CLINICAL MARKERS PREDICTIVE OF TRABECTEDIN RESPONSE IN SOFT TISSUE SARCOMA
Andri Papakonstantinou
Favorite
Papakonstantinou, Evgenia

Hellenic Society Of Pediatric Hematology- Oncology, Athens
(P 73) FOSTER CONSORTIUM, FIGHT OSTEOSARCOMA THROUGH EUROPEAN RESEARCH
Evgenia Papakonstantinou
Favorite
Parafioriti, Antonina

ASST Gaetano Pini - CTO
(P 431) TREATMENT STRATEGY AND PROGNOSTIC FACTORS IN EXTRASKELETAL EWING SARCOMA: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS
Antonina Parafioriti
Favorite
Parajuli, Gyanu

Cleveland Clinic
(P 429) SARCOMA FUSION GENE ANALYSIS YIELDS PROMISING HLA ANTIGEN FIT IN EWING SARCOMA AND DESMOPLASTIC SMALL ROUND CELL TUMOR
Gyanu Parajuli
Favorite
Paraliticci, Giovanni

Miami Cancer Institute
(P 320) A PROSPECTIVE MULTICENTER EXPERIENCE OF PROTON THERAPY FOR RHABDOMYOSARCOMA AND EWING SARCOMA: OUTCOMES FROM THE PROTON COLLABORATIVE GROUP REGISTRY
Giovanni Paraliticci
Favorite
Pareja Zea, Fresia

MSKCC
(P 103) LASTING COMPLETE RESPONSE TO PEMBROLIZUMAB IN MISMATCH REPAIR DEFICIENT CARDIAC SARCOMA: A GENOMIC CHARACTERIZATION
Fresia Pareja Zea
Favorite
Parikh, Firuza R

Jaslok hospital, Director Well Women Centre, HN reliance Hospital
(P 06) ONCOFERTILITY AND PREGNANCY IN ADOLESCENT AND YOUNG ADULT CANCERS: PHYSICIANS' KNOWLEDGE AND PREFERENCES IN A LARGE LOW-MIDDLE- INCOME COUNTRY
Firuza R Parikh
Favorite
Parikh, Tanvi

University College London
(P 563) BALANCE, GAIT AND BIOMECHANICAL COMPENSATIONS DURING DIFFERENT SPEEDS OF WALKING AFTER TREATMENT FOR DISTAL FEMORAL MUSCULOSKELETAL TUMOURS AND ASSOCIATED LIMITATIONS ON RETURN TO NORMAL LIVING
Tanvi Parikh
Favorite
Park, Ben

Vanderbilt University Medical Center
(P 160) A PROSPECTIVE STUDY EVALUATING THE ASSOCIATION OF PATIENT-REPORTED OUTCOMES WITH ACTIVITY LEVEL AND SLEEP PATTERNS IN SARCOMA SURVIVORS
Ben Park
Favorite
(P 210) FINANCIAL TOXICITY ASSOCIATED WITH THE TREATMENT OF SARCOMAS: A SINGLE INSTITUTION RETROSPECTIVE-PROSPECTIVE STUDY
Ben Park
Favorite
(P 211) AN ANALYSIS OF SELF-REPORTED DEPRESSION IN SARCOMA PATIENTS
Ben Park
Favorite
(P 218) NEOADJUVANT CHEMOTHERPAY AND RADIATION DECREASES TUMOR SIZE, VIABILITY, AND RECURRENCE IN MULTIPLE LIPOSARCOMA SUBSETS
Ben Park
Favorite
(P 380) NEXT GENERATION SEQUEINCING REVEALS TARGETABLE MUTATIONS IN MULTIPLE SARCOMA HISTOLOGIES
Ben Park
Favorite
Park, Byung

OHSU
(P 341) A PHASE 1B STUDY TO EVALUATE PREOPERATIVE ERIBULIN IN COMBINATION WITH RADIATION IN RETROPERITONEAL SARCOMA
Byung Park
Favorite
Park, Jay Hoon

Seoul National University Hospital
(P 374) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN AND LOCAL RECURRENCE: COMPREHENSIVE GENOMIC ANALYSIS IN SEARCH OF BIOMARKER OF LOCAL GROWTH PATTERN
Jay Hoon Park
Favorite
(P 498) DEDIFFERENTIATED LIPOSARCOMA OF THE EXTREMITIES: CHARACTERISTICS AND OUTCOME
Jay Hoon Park
Favorite
(P 499) CLINICAL OUTCOMES OF TOTAL FEMORAL REPLACEMENT FOR ONCOLOGICAL INDICATIONS
Jay Hoon Park
Favorite
Park, Min

Swedish Cancer Institute
(P 177) ANGIOSARCOMA: AN INCREASING PROBLEM IN THE UNITED STATES
Min Park
Favorite
Parma, Gabriella

IEO
(P 328) REAL-LIFE EXPERIENCE OF PAZOPANIB IN PATIENTS WITH ADVANCED UTERINE LEIOMYOSARCOMA (U-LMS) FROM TWO REFERRAL ITALIAN CENTERS
Gabriella Parma
Favorite
Parmar, Sahibjeet

The Life Raft Group
(P 33) LONGITUDINAL FOLLOW UP OF GASTROINTESTINAL STROMAL TUMORS:DATA FROM THE LIFE RAFT GROUP INTERANTIONAL PATIENT REGISTRY
Sahibjeet Parmar
Favorite
Parry, Michael

Royal Orthopaedic Hospital
(P 70) ICONIC (IMPROVING OUTCOMES THROUGH COLLABORATION IN OSTEOSARCOMA): A PROSPECTIVE OBSERVATIONAL COHORT STUDY FOR NEWLY DIAGNOSED OSTEOSARCOMA PATIENTS IN THE UNITED KINGDOM (UK)
Michael Parry
Favorite
(P 472) ICONIC (IMPROVING OUTCOMES THROUGH COLLABORATION IN OSTEOSARCOMA). AN EARLY LOOK AT SURGICAL DATA
Michael Parry
Favorite
Pascucci, Luisa

Department of Veterinary Medicine, University of Perugia
(P 283) A TRIDIMENSIONAL PRECLINICAL MODEL TO STUDY HUMAN AND CANINE OSTEOSARCOMA DEVELOPMENT AND INTERACTION WITH TUMOR MICROENVIRONMENT
Luisa Pascucci
Favorite
Pasquali, Sandro

Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 109) INTENSE PRECLINICAL ACTIVITY BY B7H3-SPECIFIC CAR.CIK LYMPHOCYTES AGAINST EPITHELIOID SARCOMA
Sandro Pasquali
Favorite
(P 126) CURRENT PRACTICE IN SPERMATIC CORD SARCOMA: ONCOLOGICAL TIMELINES AND OUTCOMES ACCORDING TO INITIAL RESECTIONS PERFORMED AT A LOCAL HOSPITAL VERSUS EARLY PATIENT REFERRAL TO A TERTIARY CENTRE.
Sandro Pasquali
Favorite
(P 272) A COMPARATIVE ASSESSMENT OF SELINEXOR WITH TRABECTEDIN OR LURBINECTEDIN IN PATIENT-DERIVED XENOGRAFTS (PDX) OF DEDIFFERENTIATED LIPOSARCOMA (DDLPS)
Sandro Pasquali
Favorite
(P 273) COMPARISON OF A PATIENT-DERIVED XENOGRAFTS (PDX) OF MYXOID PLEOMORPHIC LIPOSARCOMA (MPL) AND PLEOMORPHIC LIPOSARCOMA (PL) HIGHLIGHTS THE EFFECTIVENESS OF ERIBULIN IN A PDX OF MPL
Sandro Pasquali
Favorite
Pasquali, Sandro

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 363) Β-CATENIN MUTATIONS AND TRANSCRIPTOMIC REPROGRAMMING IN DESMOID FIBROMATOSIS (DF)
Sandro Pasquali
Favorite
Pasquali, Sandro

Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY
Sandro Pasquali
Favorite
(P 410) PROTEOMICS ANALYSIS IDENTIFIES A SIGNATURE THAT IMPROVES PROGNOSTIC RISK STRATIFICATION OF THE SARCULATOR NOMOGRAM IN PATIENTS WITH SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL
Sandro Pasquali
Favorite
Passiglia, Francesco

Department of Oncology, San Luigi Hospital, University of Turin
(P 550) ON-TRK: A NON-INTERVENTIONAL STUDY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION SOLID TUMORS
Francesco Passiglia
Favorite
Pastorino, Ugo

Fondazione IRCCS Istituto Nazionanale dei Tumori
(P 273) COMPARISON OF A PATIENT-DERIVED XENOGRAFTS (PDX) OF MYXOID PLEOMORPHIC LIPOSARCOMA (MPL) AND PLEOMORPHIC LIPOSARCOMA (PL) HIGHLIGHTS THE EFFECTIVENESS OF ERIBULIN IN A PDX OF MPL
Ugo Pastorino
Favorite
(P 431) TREATMENT STRATEGY AND PROGNOSTIC FACTORS IN EXTRASKELETAL EWING SARCOMA: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS
Ugo Pastorino
Favorite
(P 432) LONG-LASTING DISEASE CONTROL WITH TRABECTEDIN IN A CASE OF METASTATIC EWSR1::PATZ1 SARCOMA
Ugo Pastorino
Favorite
Pastrello, Chiara

Data Science Discovery Centre for Chronic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Canada
(P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY
Chiara Pastrello
Favorite
Patel, Anand

St. Jude Children's Research Hospital
(P 528) SAFETY AND TOLERABILITY OF ORAL CYCLOPHOSPHAMIDE AND SORAFENIB WITH INTRAVENOUS BEVACIZUMAB WITH THE ADDITION OF ATEZOLIZUMAB IN PEDIATRIC SOLID TUMOR PATIENTS
Anand Patel
Favorite
Patel, Manishkumar

Moffitt Cancer Center & Research Institute
(P 269) PLASMA DNA METHYLATION-BASED BIOMARKERS FOR MPNST DETECTION IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
Manishkumar Patel
Favorite
Patel, Pooja

University of Miami Miller School of Medicine
(P 225) PAN-SARCOMA DATABASE (PSDB): A MODEL-VIEW-CONTROLLER FRAMEWORK UTILIZING REDCAP, SHINY, AND R TO CREATE A CONTINUOUS PIPELINE OF SARCOMA DATA
Pooja Patel
Favorite
(P 366) SURVIVAL DISPARITIES IN HISPANIC PATIENTS WITH SARCOMA TESTED WITH NEXT-GENERATION SEQUENCING (NGS)
Pooja Patel
Favorite
Patel, Samir H.

Mayo Clinic Arizona
(P 312) MANAGEMENT OF ADULT HEAD AND NECK SOFT TISSUE SARCOMA: THE MAYO CLINIC EXPERIENCE
Samir H. Patel
Favorite
Patel, Shalin Shreyaskumar

The University of Texas MD Anderson Cancer Center
(P 83) CLINICO-GENOMIC PROFILING OF CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMAS REVEALS TP53 MUTATION TO BE ASSOCIATED WITH WORSE OUTCOMES
Shalin Shreyaskumar Patel
Favorite
(P 394) LEIOMYOSARCOMA INTRATUMORAL MACROPHAGE INFILTRATES ARE ASSOCIATED WITH DISTINCT CLINICAL AND GENOMIC PRESENTATIONS
Shalin Shreyaskumar Patel
Favorite
(P 529) THE MUSCULOSKELETAL TUMOR REGISTRY -- 2023 UPDATE AND OUTLOOK
Shalin Shreyaskumar Patel
Favorite
Patel, Shreyaskumar

The University of Texas MD Anderson Cancer Center
(P 36) CLINICO-GENOMIC ANALYSIS OF KIT/PDGFRA/SDH WILD-TYPE GASTROINTESTINAL STROMAL TUMORS IDENTIFIES POTENTIAL DRIVER MUTATIONS
Shreyaskumar Patel
Favorite
(P 71) CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA
Shreyaskumar Patel
Favorite
(P 83) CLINICO-GENOMIC PROFILING OF CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMAS REVEALS TP53 MUTATION TO BE ASSOCIATED WITH WORSE OUTCOMES
Shreyaskumar Patel
Favorite
(P 100) HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T)
Shreyaskumar Patel
Favorite
(P 123) DEDIFFERENTIATED LIPOSARCOMAS TREATED WITH IMMUNE CHECKPOINT BLOCKADE: THE MD ANDERSON EXPERIENCE
Shreyaskumar Patel
Favorite
(P 360) TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Shreyaskumar Patel
Favorite
(P 400) THE LANDSCAPE OF GENOMIC ALTERATIONS FROM 1494 SOFT TISSUE AND BONE SARCOMAS AT MD ANDERSON CANCER CENTER
Shreyaskumar Patel
Favorite
(P 405) PRIMARY CARDIAC ANGIOSARCOMA- GENOMIC AND MOLECULAR LANDSCAPE
Shreyaskumar Patel
Favorite
Paternostro, Flavia

Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute
(P 43) UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-ASSOCIATED PROTEIN AS A POTENTIAL NEXT GENERATION MOLECULAR TARGET FOR TREATMENT OF GASTROINTESTINAL STROMAL TUMOR
Flavia Paternostro
Favorite
(P 255) EPIDEMIOLOGY OF NOVEL ACTIONABLE TARGETS IN SYNOVIAL SARCOMA: A TISSUE MICRO-ARRAY STUDY
Flavia Paternostro
Favorite
Pathak, Harsh

KUMC
(P 446) SYNERGISTIC TARGETING OF KIF11 AND AURKA TO IMPROVE OUTCOMES FOR EWING SARCOMA
Harsh Pathak
Favorite
Patient Mosaic Team, Rare Tumor Initiative Team

MD Anderson Cancer Center
(P 100) HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T)
Rare Tumor Initiative Team Patient Mosaic Team
Favorite
Patt, Joshua

Atrium Health, Levine Cancer
(P 258) THE CRITICALITY OF OXIDATIVE PHOSPHORYLATION IN SYNOVIAL SARCOMA METASTASIS
Joshua Patt
Favorite
Paudel, Siddhi Nath

Nationwide Childrens Hospital
(P 125) MYELOMODULATORY TREATMENTS AUGMENT THE THERAPEUTIC BENEFIT OF ONCOLYTIC VIRUS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS BY MODULATING THE TUMOR MICROENVIRONMENT
Siddhi Nath Paudel
Favorite
Paulson, Kelly G.

Swedish Cancer Institute
(P 177) ANGIOSARCOMA: AN INCREASING PROBLEM IN THE UNITED STATES
Kelly G. Paulson
Favorite
Pauwels, Antoinette

The Life Raft Group
(P 33) LONGITUDINAL FOLLOW UP OF GASTROINTESTINAL STROMAL TUMORS:DATA FROM THE LIFE RAFT GROUP INTERANTIONAL PATIENT REGISTRY
Antoinette Pauwels
Favorite
Pavese, Valeria

Department of Oncology, University of Turin
(P 262) ESTABLISHMENT AND CHARACTERIZATION OF THE FIRST RADIATION-INDUCED, PATIENT-DERIVED ANGIOSARCOMA CELL LINE
Valeria Pavese
Favorite
Pawlik, Timothy

The James Cancer Hospital / The Ohio State University
(P 314) PRE-OPERATIVE RADIATION THERAPY INCREASES ADHERENCE IN PATIENTS WITH HIGH-RISK EXTREMITY SOFT TISSUE SARCOMA
Timothy Pawlik
Favorite
Payne, Emily

Huntsman Cancer Institute/University of Utah
(P 412) LEIOMYOSARCOMA POLYANEUPLOID CANCER CELLS DEVELOP IN RESPONSE TO CHEMOTHERAPY AND CONTRIBUTE TO CHEMORESISTANCE
Emily Payne
Favorite
Paz, Alejandro

Hospital Quironsalud Torrevieja
(P 407) PRECISION AND PERSONALIZED TREATMENT FOR SOFT TISSUE SARCOMAS. RESULTS OF A 10 PATIENTS SERIES WITH MOLECULAR PROFILING USING NEXT-GENERATION MASSIVE SEQUENCING
Alejandro Paz
Favorite
Pazzaglia, Laura

Istituto Ortopedico Rizzoli IOR IRCCS, Laboratory of Experimental Oncology, Bologna, Italy.
(P 01) EXTRASKELETAL EWING SARCOMA OF THE EXTREMITIES AND TRUNK IN < 25 YEARS OLD PATIENTS: A RETROSPECTIVE ANALYSIS OF A MONO-INSTITUTIONAL SERIES.
Laura Pazzaglia
Favorite
Peabody, John

Northwestern Medicine
(P 475) PRE-PLATING PRIOR TO INTERCALARY TUMOR RESECTION AND ALLOGRAFT RECONSTRUCTION: LESSONS LEARNED
John Peabody
Favorite
(P 476) FAVORABLE RESULTS FOLLOWING TREATMENT OF UNICAMERAL BONE CYSTS WITH DOXYCYCLINE SCLEROGRAFT TECHNIQUE
John Peabody
Favorite
(P 477) TREATMENT OF PROXIMAL FEMUR UNICAMERAL BONE CYSTS WITH DOXYCYCLINE SCLEROTHERAPY
John Peabody
Favorite
(P 478) TREATMENT OF CHONDROBLASTOMA WITH PERCUTANEOUS CRYOABLATION
John Peabody
Favorite
(P 479) EXPANDABLE ENDOPROSTHESES: SHOULD WE CONSIDER NARROWING OUR INDICATIONS? A SYSTEMATIC REVIEW OF THE LITERATURE AND COMPARISON OF OUTCOMES BY AGE GROUPS
John Peabody
Favorite
Peabody, Terrance

Northwestern Memorial Hospital
(P 219) ELECTIVE DISCONTINUATION OF SORAFENIB TREATMENT IN DESMOID TUMORS: A RETROSPECTIVE ANALYSIS WITH IMPLICATIONS FOR CLINICAL PRACTICE
Terrance Peabody
Favorite
(P 474) PREDICTORS OF EARLY INTROWTH AND FAILURE FOLLOWING SHORT COMPRESS SPINDLE OSSEOINTEGRATION FIXATION AT THE LOWER EXTREMITIES
Terrance Peabody
Favorite
(P 475) PRE-PLATING PRIOR TO INTERCALARY TUMOR RESECTION AND ALLOGRAFT RECONSTRUCTION: LESSONS LEARNED
Terrance Peabody
Favorite
(P 476) FAVORABLE RESULTS FOLLOWING TREATMENT OF UNICAMERAL BONE CYSTS WITH DOXYCYCLINE SCLEROGRAFT TECHNIQUE
Terrance Peabody
Favorite
(P 477) TREATMENT OF PROXIMAL FEMUR UNICAMERAL BONE CYSTS WITH DOXYCYCLINE SCLEROTHERAPY
Terrance Peabody
Favorite
(P 478) TREATMENT OF CHONDROBLASTOMA WITH PERCUTANEOUS CRYOABLATION
Terrance Peabody
Favorite
(P 479) EXPANDABLE ENDOPROSTHESES: SHOULD WE CONSIDER NARROWING OUR INDICATIONS? A SYSTEMATIC REVIEW OF THE LITERATURE AND COMPARISON OF OUTCOMES BY AGE GROUPS
Terrance Peabody
Favorite
(P 480) TARGETED MUSCLE REINNERVATION FOR HIP DISARTICULATION - EVALUATION OF EARLY FUNCTIONAL OUTCOMES
Terrance Peabody
Favorite
(P 481) CUSTOM ADAPTERS FOR COMPRESS SPINDLE OSSEOINTEGRATION FIXATION IN REVISION LIMB SALVAGE SURGERY OF THE DISTAL FEMUR: A CASE SERIES
Terrance Peabody
Favorite
Peairs, Emily

Duke University School of Medicine
(P 72) CO-EXPRESSION OF LEUKOCYTE CYTOSOLIC PROTEIN 1 AND MATRIX METALLOPROTEINASES ARE INTEGRAL FOR METASTATIC PROGRESSION OF CHONDROSARCOMA
Emily Peairs
Favorite
(P 137) IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON SARCOMA CARE: A SINGLE INSTITUTION EXPERIENCE
Emily Peairs
Favorite
Peiro Ibañez, Ana

Hospital de la Santa Creu i Sant Pau
(P 503) SCAPULAR PROSTHESIS RECONSTRUCTION, EXPERIENCE IN OUR INSTITUTION
Ana Peiro Ibañez
Favorite
(P 504) WHY DO SOME PATIENTS WITH SYNOVIAL SARCOMA HAVE BETTER FUNCTIONAL OUTCOMES AFTER RESECTION SURGERY? ANALYSIS OF 102 CASES
Ana Peiro Ibañez
Favorite
(P 507) PRIMARY CHEST WALL TUMORS OF MESENCHYMAL ORIGIN. EXPERIENCE OF A REFERENCE UNIT
Ana Peiro Ibañez
Favorite
(P 508) DREAM, UTOPIA OR REALISM? PROGNOSTIC FACTORS IN LUNG METASTASECTOMY OF DISSEMINATED SARCOMA DISEASE
Ana Peiro Ibañez
Favorite
Pelak, Maciej

MedAustron Ion therapy Center, Austria
(P 326) CARBON-ION RADIOTHERAPY FOR UNRESECTABLE PELVIC SARCOMAS/CHORDOMAS
Maciej Pelak
Favorite
Pellegrini, Ilaria

Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 333) SYSTEMIC TREATMENT IN INTRA-ABDOMINAL DESMOID-TYPE FIBROMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE CASE SERIES ANALYSIS
Ilaria Pellegrini
Favorite
Peltzer, Alexander

Boehringer Ingelheim Pharma GmbH & Co. KG, Department of Translational Medicine & Clinical Pharmacology
(P 185) LONGITUDINAL MUTATIONAL ANALYSIS OF TP53 IN CIRCULATING TUMOR DNA IN THE PLASMA OF PATIENTS WITH LIPOSARCOMA IN A PHASE I STUDY OF BRIGIMADLIN (BI 907828), AN MDM2-P53 ANTAGONIST
Alexander Peltzer
Favorite
Pencreach, Erwan

University Hospital of Strasbourg
(P 389) OSTEOBLASTIC-GENE SIGNATURE TO PREDICT SURVIVAL IN PEDIATRIC OSTEOSARCOMA (OS) AND TO FOLLOW PATIENTS TOWARDS LIQUID BIOPSY: A COLLABORATIVE WORK IN OS2006 PROTOCOL.
Erwan Pencreach
Favorite
Pendegrass, Catherine

University College London
(P 147) UNDERSTANDING THE EXPERIENCES OF PATIENTS RETURNING TO DAILY ACTIVITES AND EXERCISE FOLLOWING LIMB SPARING SURGERY FOR BONE OR SOFT TISSUE SARCOMA AROUND THE KNEE
Catherine Pendegrass
Favorite
(P 492) BALANCE AND GAIT OUTCOMES AFTER 1-YEAR POST-OPERATIVE HEMIPELVECTOMY SURGERY
Catherine Pendegrass
Favorite
(P 493) GAIT KINEMATICS OF SARCOMA PATIENTS AT 1 YEAR POST-OPERATIVE INTERNAL HEMIPELVECTOMY SURGERY: A RETROSPECTIVE STUDY.
Catherine Pendegrass
Favorite
(P 494) WHAT IS THE EXPERIENCE OF THOSE WITH CANCER-RELATED REDUCED QUALITY OF LIFE AND ASSOCIATED PHYSICAL DISABILITIES AFTER UPPER LIMB SARCOMA TREATMENT IN ENGLAND? A NATIONAL STUDY OF OUTCOMES.
Catherine Pendegrass
Favorite
(P 495) UNDERSTANDING THE EXPERIENCES OF PATIENTS RETURNING TO ACTIVITIES OF DAILY LIVING AND EXERCISE FOLLOWING LIMB SPARING SURGERY FOR BONE OR SOFT TISSUE SARCOMA AROUND THE KNEE.
Catherine Pendegrass
Favorite
(P 496) WHAT ARE THE EXPERIENCES OF BALANCE, GAIT AND NEURO-MUSCULAR CONTROL OUTCOMES AFTER PROXIMAL FEMORAL REPLACEMENTS FOR MUSCULOSKELETAL TUMOURS?
Catherine Pendegrass
Favorite
(P 519) WHAT ARE THE EXPERIENCES OF GAIT, ACTIVITY LEVELS AND PHYSICAL FUNCTIONING IN PROXIMAL FEMORAL REPLACEMENT AFTER MUSCULOSKELETAL TUMORS?
Catherine Pendegrass
Favorite
(P 560) REAL-WORLD MONITORING OF PHYSICAL ACTIVITY USING AN ACCELEROMETER AFTER LOWER LIMB SURGERY FOR A SARCOMA.
Catherine Pendegrass
Favorite
(P 561) EXPERIENCE OF PHYSICAL DISABILITIES AND CANCER-RELATED QUALITY OF LIFE AFTER SPINAL TUMORS- STUDY OF A NATIONAL SURVEY IN ENGLAND.
Catherine Pendegrass
Favorite
(P 563) BALANCE, GAIT AND BIOMECHANICAL COMPENSATIONS DURING DIFFERENT SPEEDS OF WALKING AFTER TREATMENT FOR DISTAL FEMORAL MUSCULOSKELETAL TUMOURS AND ASSOCIATED LIMITATIONS ON RETURN TO NORMAL LIVING
Catherine Pendegrass
Favorite
Penel, Nicolas

Centre Oscar Lambret
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
Nicolas Penel
Favorite
Pennacchioli, Elisabetta

Division of Melanoma, Sarcoma, and Rare Tumor Surgery, European Institute of Oncology
(P 342) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
Elisabetta Pennacchioli
Favorite
Penna, Giuseppe

Humanitas University
(P 297) UNVEILING THE IMPACT OF INTRATUMORAL MICROBIOTA IN THE TREATMENT EFFICACY OF SOFT TISSUE SARCOMA
Giuseppe Penna
Favorite
Percio, Stefano

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 363) Β-CATENIN MUTATIONS AND TRANSCRIPTOMIC REPROGRAMMING IN DESMOID FIBROMATOSIS (DF)
Stefano Percio
Favorite
Peretz Soroka, Hagit

Princess Margaret Cancer Centre / The Hospital For Sick Children
(P 215) IMPACT OF FRONTLINE SYSTEMIC TREATMENT CHOICE ON CLINICAL OUTCOME IN ADVANCED LEIOMYOSARCOMA: A MULTI-CENTRE RETROSPECTIVE CANSARCC STUDY
Hagit Peretz Soroka
Favorite
(P 421) USING TRANSCRIPTOMICS TO IDENTIFY LEIOMYOSARCOMA PATIENTS AT RISK OF METASTASIS
Hagit Peretz Soroka
Favorite
Perez Campos, Antonio

Cebiotex S.L., Barcelona, Spain
(P 385) FIRST IN HUMAN PHASE I TRIAL OF A NOVEL DRUG DELIVERY IMPLANT MATRIX WITH SN-38 (CEB-01) FOR RETROPERITONEAL SOFT TISSUE SARCOMA
Antonio Perez Campos
Favorite
Perez, Esperanza

Gustave Roussy
(P 73) FOSTER CONSORTIUM, FIGHT OSTEOSARCOMA THROUGH EUROPEAN RESEARCH
Esperanza Perez
Favorite
Perot, Gaëlle

Cancer Research Center of Toulouse
(P 104) COMPREHENSIVE IMMUNE PROFILING UNVEILS A SUBSET OF LEIOMYOSARCOMA WITH HOT TUMOR IMMUNE MICROENVIRONMENT
Gaëlle Perot
Favorite
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
Gaëlle Perot
Favorite
(P 268) IMPACT OF CELLULAR FUSION IN THE ONCOGENESIS OF LEIOMYOSARCOMAS
Gaëlle Perot
Favorite
Perrin, Virginie

CENTRE LEON BERARD AND CANCER RESEARCH CENTER OF LYON (INSERM U1052-CNRS5286)
(P 435) ONCOGENIC FUSION YWHAE::NUTM2 DISRUPT EP300/BCOR INTERACTION
Virginie Perrin
Favorite
Perrone, Federica

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 363) Β-CATENIN MUTATIONS AND TRANSCRIPTOMIC REPROGRAMMING IN DESMOID FIBROMATOSIS (DF)
Federica Perrone
Favorite
PERSARC research group, VALUE-

Leiden University Medical Center
(P 132) SARCOMA PATEINTS' VIEWS ON USING A RISK-PREDICTION MODEL TO INFORM TREATMENT DECISIONS.
VALUE- PERSARC research group
Favorite
Pestana, Roberto

Hospital Israelita Albert Einstein
(P 360) TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Roberto Pestana
Favorite
Petersen, Ivy

Mayo Clinic
(P 02) PEDIATRIC SYNOVIAL SARCOMA: A REVIEW OF 21 CASES FROM A SINGLE INSTITUTION
Ivy Petersen
Favorite
(P 306) USE OF PENCIL BEAM SCANNING PROTON RADIOTHERAPY IN MOBILE SPINE CHORDOMAS
Ivy Petersen
Favorite
(P 465) UNPLANNED EXCISION OF SYNOVIAL SARCOMA: FACTORS ASSOCIATED WITH RECURRENCE AND SURVIVAL
Ivy Petersen
Favorite
(P 518) OUTCOMES OF NON-ANGIOSARCOMA RADIATION-ASSOCIATED SOFT TISSUE SARCOMAS OF THE CHEST
Ivy Petersen
Favorite
Peterson, Christine

The University of Texas MD Anderson Cancer Center
(P 269) PLASMA DNA METHYLATION-BASED BIOMARKERS FOR MPNST DETECTION IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
Christine Peterson
Favorite
Peters, Solange

CHUV
(P 535) THERAGNOSTICS IN SOFT TISSUE SARCOMA USING A VASCULAR DISCRUPTION APPROACH
Solange Peters
Favorite
Petit, Arnaud

APHP. Sorbonne Université, Hopital Armand Trouseau
(P 212) REPORT ON THE EWING SARCOMA PATIENTS ENROLLED IN ARM D OF THE ACSE-ESMART TRIAL: PHASE I/II STUDY OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IRINOTECAN IN CHILDREN WITH ADVANCED MALIGNANCIES
Arnaud Petit
Favorite
Petrini, Massimiliano

IRST
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
Massimiliano Petrini
Favorite
Petrochenko, Nikolay

National Medical Research Center of Oncology named after N.N. Blokhin "of the Ministry of Health of the Russian Federation
(P 459) EXPERIENCE IN THE USE OF INDIVIDUALIZED 3D-IMPLANTS IN THE RECONSTRUCTION OF DEFECTS IN PATIENTS WITH TUMORS OF THE CHEST WALL
Nikolay Petrochenko
Favorite
Petrongari, Maria Grazia

IRCCS Istituto Nazionale Tumori Regina Elena, Rome, Italy
(P 74) SACRAL CHORDOMA: A RANDOMIZED & OBSERVATIONAL STUDY ON SURGERY VS DEFINITIVE RADIOTHERAPY IN PRIMARY LOCALIZED DISEASE (SACRO). INTERIM ANALYSIS
Maria Grazia Petrongari
Favorite
Petrosyan, Mikael

Children's National Hospital
(P 18) RETROSPECTIVE ANALYSIS ON OUTCOMES PEDIATRIC PATIENTS WITH SARCOMA AND LUNG METASTASES STATUS POST PNEUMONECTOMY VERSUS PARTIAL LUNG RESECTION
Mikael Petrosyan
Favorite
Piana, Raimondo

Azienda Ospedaliera Citta della Salute e della Scienza di Torino
(P 69) DEVELOPMENT AND MISSION OF THE HARMONIZATION INTERNATIONAL BONE SARCOMA CONSORTIUM (HIBISCUS)
Raimondo Piana
Favorite
Piccinelli, Paul

Skåne University Hospital
(P 372) COPY NUMBER GAIN OF MDM2 IN ROD-SHAPED CHROMOSOMES PROVIDES CLUES TO EARLY STAGES IN CIRCULARIZED GENE AMPLIFICATION IN LIPOSARCOMA
Paul Piccinelli
Favorite
Piccione, Emily

Inhibrx, Inc
(P 439) THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 COMBINED WITH CHEMOTHERAPY IN EWING SARCOMA: PRELIMINARY DATA FROM A PHASE 1 STUDY
Emily Piccione
Favorite
Piel, Jessica

Foghorn Therapeutics
(P 271) PHARMACODYNAMICS AND MECHANISTIC IMPACTS OF FHD-609, A BROMODOMAIN-CONTAINING PROTEIN 9 DEGRADER, IN A PHASE 1 STUDY IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR SMARCB1-LOSS TUMORS
Jessica Piel
Favorite
Pienkowski, Andrzej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 95) LONG-TERM OUTCOMES OF PATIENTS DIAGNOSED WITH CHORDOMA OF THE SACRUM
Andrzej Pienkowski
Favorite
Pienta, Kenneth

Johns Hopkins School of Medicine
(P 412) LEIOMYOSARCOMA POLYANEUPLOID CANCER CELLS DEVELOP IN RESPONSE TO CHEMOTHERAPY AND CONTRIBUTE TO CHEMORESISTANCE
Kenneth Pienta
Favorite
Pieri, Federica

Pathology Unit, "Morgagni-Pierantoni" Hospital
(P 37) DISSECTING THE ROLE OF EXTRACELLULAR VESICLES IN THE MANAGEMENT OF GIST
Federica Pieri
Favorite
Pieri, Federica

Pathology Unit, "Morgagni-Pierantoni" Hospital, 47121 Forlì, Italy
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
Federica Pieri
Favorite
Pieri, Federica

Pathology Unit, "Morgagni-Pierantoni" Hospital
(P 364) EVALUATION OF THE PREDICTIVE ROLE OF SYSTEMIC AND INTRATUMORAL IMMUNITY IN PATIENTS WITH LOCALIZED LIPOSARCOMAS, MYXOFIBROSARCOMAS AND UNDIFFERENTIATED PLEOMORPHIS SARCOMAS
Federica Pieri
Favorite
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
Federica Pieri
Favorite
Pierini, Michela

IRCCS Istituto Ortopedico Rizzoli
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Michela Pierini
Favorite
Pierrevelcin, Marina

UMR CNRS 7021
(P 277) ANTI-GD2 SYNERGIZES WITH HYPOXIA PATHWAY TARGETING TO BLOCK OSTEOSARCOMA CELL PROLIFERATION AND MIGRATION.
Marina Pierrevelcin
Favorite
Pietrok, Laura

Cerberus Therapeutics
(P 115) EFFICACY AND CORREALTIVE ANALYSIS OF USING NEOADJUVANT INTRATUMORAL HIGH DOSE TALIMOGENE LAHERPAREPVEC (TVEC) WITH CONCURRENT RADIATION IN HIGH-RISK EXTREMITY AND TRUNK SOFT-TISSUE SARCOMAS
Laura Pietrok
Favorite
Pignochino, Ymera

Candiolo Cancer Institute IRCCS FPO
(P 262) ESTABLISHMENT AND CHARACTERIZATION OF THE FIRST RADIATION-INDUCED, PATIENT-DERIVED ANGIOSARCOMA CELL LINE
Ymera Pignochino
Favorite
Pilar, Avinash

University College London Hospital
(P 92) DOSIMETRIC CHARACTERISTICS, OUTCOMES AND PROGNOSTIC FACTORS OF PATIENTS WITH EXTRACRANIAL CHORDOMAS AND CHONDROSARCOMAS TREATED WITH HIGH DOSE RADIOTHERAPY: A LARGE SINGLE INSTITUTION COHORT
Avinash Pilar
Favorite
(P 325) OUTCOMES AFTER MODERN THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY AND INTENSITY MODULATED RADIOTHERAPY TO TREAT SARCOMAS ARISING IN THE HAND: A RETROSPECTIVE SERIES
Avinash Pilar
Favorite
Pilgermann, Kai

Sarcoma Patient Advocacy Global Network (SPAGN)
(P 136) SETTING THE INTERNATIONAL RESEARCH AGENDA FOR SARCOMA WITH PATIENTS AND CARERS: PRELIMINARY RESULTS OF PHASE II OF THE SARCOMA PATIENT ADVOCACY GLOBAL NETWORK (SPAGN) PRIORITY SETTING PARTNERSHIP
Kai Pilgermann
Favorite
Pillay, Nischalan

University College London, Cancer Institute
(P 04) THE CELL ATLAS OF CLEAR CELL SARCOMA
Nischalan Pillay
Favorite
(P 381) THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA
Nischalan Pillay
Favorite
Pink, Daniel

Helios Hospital Bad Saarow, Sarcoma Centre Berlin-Brandenburg, Department of Hematology, Oncology and Palliative Care
(P 135) UNMET NEEDS IN LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC DEDIFFERENTIATED LIPOSARCOMA AND EXPECTATIONS FOR CLINICAL TRIALS: AN INTERNATIONAL DELPHI CONSENSUS STUDY
Daniel Pink
Favorite
Pinto, Navin

Seattle Children’s Hospital
(P 03) EVOLUTION OF CLINICALLY ACTIONABLE VARIANTS IN ADVANCED PEDIATRIC AND AYA BONE SARCOMAS
Navin Pinto
Favorite
(P 542) ENROLLMENT OF PEDIATRIC PARTICIPANTS WITH MAGE-A4-POSITIVE SOLID TUMORS IN A PHASE 1/2, OPEN-LABEL, BASKET TRIAL OF AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")
Navin Pinto
Favorite
Pionelli, Maria Grazia

AORN Santobono-Pausilipon
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Maria Grazia Pionelli
Favorite
Piorkowska, Karolina

Hospital for Sick Children
(P 108) EFFECT OF TUMOUR-TARGETED HYPERTHERMIA AND CHEMOTHERAPY ON THE IMMUNE PROFILE OF A MURINE MODEL OF EMBRYONAL RHABDOMYOSARCOMA
Karolina Piorkowska
Favorite
Piperno-Neumann, Sophie

Institut Curie
(P 389) OSTEOBLASTIC-GENE SIGNATURE TO PREDICT SURVIVAL IN PEDIATRIC OSTEOSARCOMA (OS) AND TO FOLLOW PATIENTS TOWARDS LIQUID BIOPSY: A COLLABORATIVE WORK IN OS2006 PROTOCOL.
Sophie Piperno-Neumann
Favorite
Pissaloux, Daniel

CENTRE LEON BERARD AND CANCER RESEARCH CENTER OF LYON (INSERM U1052-CNRS5286)
(P 382) NTRK1/2/3 FUSIONS DETECTION USING RNA-SEQ IN MESENCHYMAL TUMORS REVEALS ULTRA-RARE AND HISTO-SPECIFIC TARGETABLE ALTERATIONS: EXPERIENCE OF AN EXTENSIVE ROUTINE RESEARCH PROGRAM.
Daniel Pissaloux
Favorite
(P 435) ONCOGENIC FUSION YWHAE::NUTM2 DISRUPT EP300/BCOR INTERACTION
Daniel Pissaloux
Favorite
Placzke, Joanna

Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland
(P 21) YOUNG ADULTS WITH NONMETASTATIC OPERABLE OSTEOSARCOMA TREATED PERIOPERATIVELY WITH METHOTREXATE, DOXORUBICIN AND CISPLATIN SCHEDULE, SINGLE INSTITUTION REPORT
Joanna Placzke
Favorite
Planas Canovas, Georgina

Hospital de la Santa Creu i Sant Pau
(P 507) PRIMARY CHEST WALL TUMORS OF MESENCHYMAL ORIGIN. EXPERIENCE OF A REFERENCE UNIT
Georgina Planas Canovas
Favorite
(P 508) DREAM, UTOPIA OR REALISM? PROGNOSTIC FACTORS IN LUNG METASTASECTOMY OF DISSEMINATED SARCOMA DISEASE
Georgina Planas Canovas
Favorite
Plaumann, Pauline

Pediatrics III, University Hospital Essen, West German Cancer Center
(P 17) METASTASIS-SPECIFIC GENE EXPRESSION PATTERNS IN EWING SARCOMA
Pauline Plaumann
Favorite
Pleasance, Erin

BC Cancer
(P 104) COMPREHENSIVE IMMUNE PROFILING UNVEILS A SUBSET OF LEIOMYOSARCOMA WITH HOT TUMOR IMMUNE MICROENVIRONMENT
Erin Pleasance
Favorite
Podleska, Lars-Erik

Department of Musculoskeletal Oncology, West German Cancer Center, University Hospital Essen
(P 220) [68GA]GA-FAPI PET/CT AS NOVEL DIAGNOSTIC TOOL IN SARCOMA
Lars-Erik Podleska
Favorite
Poklepovic, Andrew

Virginia Commonwealth University
(P 207) A MULTICENTER PHASE II STUDY OF CABOZANTINIB PLUS NIVOLUMAB FOR PATIENTS WITH ADVANCED ANGIOSARCOMA PREVIOUSLY TREATED WITH A TAXANE: ALLIANCE A091902
Andrew Poklepovic
Favorite
Polignano, Maggie

INT Milan
(P 328) REAL-LIFE EXPERIENCE OF PAZOPANIB IN PATIENTS WITH ADVANCED UTERINE LEIOMYOSARCOMA (U-LMS) FROM TWO REFERRAL ITALIAN CENTERS
Maggie Polignano
Favorite
Pollack, Seth

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
(P 96) LEPTOMENINGEAL RECURRENCE OF EWING'S SARCOMA: A CASE SERIES
Seth Pollack
Favorite
(P 112) PHASE 1/2 STUDY OF YH001, A CTLA-4 ANTIBODY WITH THE SUBCUTANEOUSLY ADMINISTERED PD-L1 ANTIBODY ENVAFOLIMAB, WITH OR WITHOUT DOXORUBICIN IN PATIENTS WITH ADVANCED OR METASTATIC SOFT TISSUE SARCOMA
Seth Pollack
Favorite
(P 180) HEALTH RELATED QUALITY OF LIFE OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA AND OTHER SOFT TISSUE SARCOMAS TREATED WITH CABOZANTINIB AND TEMOZOLOMIDE
Seth Pollack
Favorite
(P 206) A SINGLE-ARM, PHASE II STUDY OF NEOADJUVANT PEMBROLIZUMAB COMBINED WITH RADIOTHERAPY IN THE PRIMARY TREATMENT OF SOFT TISSUE SARCOMAS.
Seth Pollack
Favorite
(P 219) ELECTIVE DISCONTINUATION OF SORAFENIB TREATMENT IN DESMOID TUMORS: A RETROSPECTIVE ANALYSIS WITH IMPLICATIONS FOR CLINICAL PRACTICE
Seth Pollack
Favorite
Pollard, Kai

John Hopkins University
(P 250) SHARING HIGH-QUALITY SAMPLES AND DATA TO THE NF1 RESEARCH COMMUNITY: THE ROLE OF THE JOHNS HOPKINS NF1 BIOSPECIMEN REPOSITORY
Kai Pollard
Favorite
(P 274) TYK2 AND MEK COMBINATION THERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS AND OTHER SOFT TISSUE SARCOMAS
Kai Pollard
Favorite
Pollock, Raphael

The James Cancer Hospital / The Ohio State University
(P 301) REDUCING THE INVASIVE POTENTIAL OF DEDIFFERENTIATED LIPOSARCOMA BY TARGETING ALTERNATIVE RNA SPLICING MACHINERY
Raphael Pollock
Favorite
(P 314) PRE-OPERATIVE RADIATION THERAPY INCREASES ADHERENCE IN PATIENTS WITH HIGH-RISK EXTREMITY SOFT TISSUE SARCOMA
Raphael Pollock
Favorite
(P 335) EXTRACELLULAR VESICLE MDM2 DNA AS A BIOMARKER OF TUMOR PRESENCE AND RECURRENCE IN RETROPERITONEAL LIPOSARCOMA
Raphael Pollock
Favorite
(P 347) INCIDENCE AND TIMING OF RECURRENCE AFTER ADJUVANT PALBOCICLIB IN COMPLETELY RESECTED RETROPERITONEAL LIPOSARCOMA
Raphael Pollock
Favorite
Poon, Andrew

University of Guelph
(P 304) A COMPARATIVE ANALYSIS OF METABOLIC FLEXIBILITY IN OSTEOSARCOMA CELLS
Andrew Poon
Favorite
Portney, Daniel

University of Chicago
(P 479) EXPANDABLE ENDOPROSTHESES: SHOULD WE CONSIDER NARROWING OUR INDICATIONS? A SYSTEMATIC REVIEW OF THE LITERATURE AND COMPARISON OF OUTCOMES BY AGE GROUPS
Daniel Portney
Favorite
Posey, Kristi

MD Anderson Cancer Center
(P 71) CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA
Kristi Posey
Favorite
Poumeaud, François

Oncopole Claudius Regaud
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
François Poumeaud
Favorite
Powers, Benjamin

The University of Kansas Health System
(P 214) SIGNIFICANT TREATMENT RESPONSE IN PATIENTS WITH PRIMARY RESECTABLE EXTREMITY MYXOID LIPOSARCOMA RECEIVING NEOADJUVANT TRABECTEDIN AND RADIATION
Benjamin Powers
Favorite
Pratilas, Christine

The Johns Hopkins Hospital
(P 143) EXPLORING HOSPITAL VOLUME THRESHOLDS FOR IMPROVED SARCOMA TREATMENT ACROSS DIFFERENT AGE CATEGORIES IN THE UNITED STATES
Christine Pratilas
Favorite
Pratilas, Christine

Johns Hopkins University
(P 250) SHARING HIGH-QUALITY SAMPLES AND DATA TO THE NF1 RESEARCH COMMUNITY: THE ROLE OF THE JOHNS HOPKINS NF1 BIOSPECIMEN REPOSITORY
Christine Pratilas
Favorite
(P 274) TYK2 AND MEK COMBINATION THERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS AND OTHER SOFT TISSUE SARCOMAS
Christine Pratilas
Favorite
(P 551) PHASE II TRIAL OF GEMCITABINE AND NAB-PACLITAXEL IN PATIENTS WITH RECURRENT RHABDOMYOSARCOMA: A CLINICAL TRIAL IN PROGRESS FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Christine Pratilas
Favorite
Prenen, Hans

University Hospital Antwerp
(P 27) A MULTICENTER RETROSPECTIVE STUDY ON THE CLINICAL BEHAVIOR OF SDH-DEFICIENT GIST
Hans Prenen
Favorite
Pressey, Joseph

Cincinnati Children’s Hospital
(P 178) INITIAL RESULTS FROM A PHASE 1 STUDY OF CFT8634, A NOVEL BIFUCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Joseph Pressey
Favorite
Preston, Jessica

Veramed
(P 114) PRIMARY ANALYSIS OF EFFICACY AND SAFETY OF LETETRESGENE AUTOLEUCEL (LETE-CEL) AS FIRST-LINE TREATMENT FOR UNRESECTABLE OR METASTATIC SYNOVIAL SARCOMA (SS); SUBSTUDY 1 OF IGNYTE-ESO
Jessica Preston
Favorite
Presutti, Laura

Rocky Vista College of Medicine
(P 373) DEDIFFERENTIATED AND HIGH GRADE CHONDROSARCOMAS: HOW DOES ISOCITRATE DEHYDROGENASE STATUS APPRISE PROGNOSIS AND THERAPY?
Laura Presutti
Favorite
Pretell-Mazzini, Juan

Miami Cancer Institute
(P 320) A PROSPECTIVE MULTICENTER EXPERIENCE OF PROTON THERAPY FOR RHABDOMYOSARCOMA AND EWING SARCOMA: OUTCOMES FROM THE PROTON COLLABORATIVE GROUP REGISTRY
Juan Pretell-Mazzini
Favorite
(P 485) SUBTROCHANTERIC NON-UNION AFTER INTRAMEDULLARY NAILING DUE TO PATHOLOGICAL FRACTURE:PROXIMAL FEMORAL REPLACEMENT AS A SALVAGE APPROACH
Juan Pretell-Mazzini
Favorite
Price, Bradley

Action for Pulmonary Fibrosis
(P 151) DEVELOPMENT AND IMPACT OF A PRIMARY CARE SARCOMA EDUCATION MODULE FOR ENGLAND AND WALES
Bradley Price
Favorite
Priebe, Waldemar

Experimental Therapeutics, MD Anderson Cancer Center/ Moleculin Biotech, Inc
(P 183) A PHASE 1B/2 STUDY OF LIPOSOMAL ANNAMYCIN (ANN) IN SUBJECTS WITH PREVIOUSLY TREATED SOFT-TISSUE SARCOMAS (STS) WITH PULMONARY METASTASES
Waldemar Priebe
Favorite
Prieto Granada, Carlos

Vanderbilt University Medical Center
(P 218) NEOADJUVANT CHEMOTHERPAY AND RADIATION DECREASES TUMOR SIZE, VIABILITY, AND RECURRENCE IN MULTIPLE LIPOSARCOMA SUBSETS
Carlos Prieto Granada
Favorite
Prior, John

CHUV
(P 535) THERAGNOSTICS IN SOFT TISSUE SARCOMA USING A VASCULAR DISCRUPTION APPROACH
John Prior
Favorite
Prokopishyn, Nicole

Alberta Precision Laboratories
(P 110) GCAR1: GPNMB CAR T THERAPY FOR MIT FAMILY TRANSLOCATION POSITIVE CANCERS
Nicole Prokopishyn
Favorite
Proment, Alessia

Department of Oncology, University of Turin
(P 109) INTENSE PRECLINICAL ACTIVITY BY B7H3-SPECIFIC CAR.CIK LYMPHOCYTES AGAINST EPITHELIOID SARCOMA
Alessia Proment
Favorite
Prough, Haley

Cleveland Clinic Foundation
(P 514) INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF SOFT TISSUE SARCOMA: LOCAL RECURRENCE AND WOUND OUTCOMES
Haley Prough
Favorite
Provenzano, Salvatore

Mesenchymal and rare cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Salvatore Provenzano
Favorite
(P 333) SYSTEMIC TREATMENT IN INTRA-ABDOMINAL DESMOID-TYPE FIBROMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE CASE SERIES ANALYSIS
Salvatore Provenzano
Favorite
(P 431) TREATMENT STRATEGY AND PROGNOSTIC FACTORS IN EXTRASKELETAL EWING SARCOMA: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS
Salvatore Provenzano
Favorite
(P 432) LONG-LASTING DISEASE CONTROL WITH TRABECTEDIN IN A CASE OF METASTATIC EWSR1::PATZ1 SARCOMA
Salvatore Provenzano
Favorite
Provenzano, Salvatore

Adult mesenchymal tumours and rare cancers unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Ital
(P 437) ULTRA-RARE UNDIFFERENTIATED SMALL ROUND CELL SARCOMA: HOW SHOULD WE TREAT THEM? AN ANALYSIS FORM THE GRACEFUL PROJECT
Salvatore Provenzano
Favorite
Provenzano, Salvatore

Mesenchymal and rare cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Salvatore Provenzano
Favorite
Przybyl, Joanna

McGill University
(P 367) CHARACTERIZING HYPOXIA AND ASSOCIATED MOLECULAR FEATURES IN EXTREMITY SOFT TISSUE SARCOMA
Joanna Przybyl
Favorite
(P 376) MULTI-OMIC PROFILING OF LEIOMYOSARCOMA IDENTIFIES MARKERS PREDICTIVE OF RESPONSE TO GEMCITABINE AND DOCETAXEL
Joanna Przybyl
Favorite
Puiseux, Chloe

Gilles.Vassal@gustaveroussy.fr
(P 75) REAL-WORLD DATA ON REGORAFENIB AND CABOZANTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OSTEOSARCOMA AND EWING SARCOMA INCLUDED IN THE SACHA-FRANCE STUDY
Chloe Puiseux
Favorite
Purgina, Bibianna

The Ottawa Hospital
(P 98) TUMOR IMMUNE PROFILING AND IDENTIFICATION OF IMMUNOTHERAPEUTIC TARGETS IN DEDIFFERENTIATED LIPOSARCOMA
Bibianna Purgina
Favorite
Puri, Rajni

KUMC
(P 446) SYNERGISTIC TARGETING OF KIF11 AND AURKA TO IMPROVE OUTCOMES FOR EWING SARCOMA
Rajni Puri
Favorite
Purnamasari, Mia

Essen University Hospital
(P 275) GIST-BSF1: A NOVEL SCF-DEPENDENT, WILD-TYPE KIT CELL LINE PLATFORM THAT ALLOWS RAPID GENERATION OF ISOGENIC SUBLINES WITH BOTH IMATINIB-SENSITIVE AND IMATINIB-RESISTANT GENOTYPES
Mia Purnamasari
Favorite
Puviindran, Vijitha

Duke University
(P 375) IDENTIFICATION OF METASTATIC CELLS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: SINGLE CELL RNA SEQUENCING AND CIBERSORT ANALYSIS
Vijitha Puviindran
Favorite
(P 393) INVESTIGATING THE ROLE OF HDACS IN THE PROGRESSION OF METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Vijitha Puviindran
Favorite